Patents by Inventor Carolyn Hoyal-Wrightson

Carolyn Hoyal-Wrightson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Identifying Risk of Low Bmd and Treatments Thereof
    Publication number: 20070292849
    Abstract: Provided herein are methods for identifying a risk of low BMD in a subject, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating low BMD-related disorders, such as osteoporosis, and therapeutic and preventative methods applicable to osteoporosis. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: December 29, 2005
    Publication date: December 20, 2007
    Inventors: Steven Mah, Carolyn Hoyal-Wrightson, Stefan Kammerer, Matthew Nelson, Andreas Braun, Rikard Reneland
  • Methods for identifying risk of breast cancer and treatments thereof
    Publication number: 20050272043
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: May 27, 2004
    Publication date: December 8, 2005
    Inventors: Richard Roth, Andreas Braun, Stefan Kammerer, Matthew Nelson, Rikard Reneland, Carolyn Hoyal-Wrightson
  • Methods for identifying risk of melanoma and treatments thereof
    Publication number: 20050233341
    Abstract: Provided herein are methods for identifying risk of melanoma in a subject and/or subjects at risk of melanoma, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating melanoma, therapeutic methods for treating melanoma in a subject and compositions comprising one or more melanoma cells and one or more NRP1, NID2, ENDO180, CDK10, FPGT, CARK, PCLO or REPS2 directed agents. These embodiments are based upon an analysis of polymorphic variations in a NRP1, NID2, ENDO180, CDK10, FPGT, CARK, PCLO or REPS2 nucleic acid, exemplified by nucleotide sequences of SEQ ID NO: 1-17.
    Type: Application
    Filed: May 5, 2004
    Publication date: October 20, 2005
    Inventors: Richard Roth, Matthew Nelson, Stefan Kammerer, Andreas Braun, Carolyn Hoyal-Wrightson